logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
26/09/2025
Standard & Poor's: The fiscal and external buffers of Trinidad and Tobago have been gradually weakening for a long time; long-term economic growth has been sluggish.
Latest
2 m ago
Asian markets opened this morning with a slight decrease in gold prices, as position adjustments are likely to occur before the release of key economic data in the United States.
3 m ago
Bolivian President Arce attended the 80th session of the United Nations General Assembly on the 25th and delivered a speech condemning the United States for pursuing a "new Monroe Doctrine" in an attempt to regain control of Latin America and the Caribbean region and make them subjugated to US interests. Arce stated that the US government's insistence on restoring US hegemony in the Western Hemisphere is a "new form of Monroe Doctrine," with its essence still being the hegemonic logic of "America for Americans." In doing so, the United States is willing to deviate from free trade and globalization trends and attempt to turn Latin America into a "dam" hindering the construction of a multipolar world to serve US interests. (Xinhua)
4 m ago
Trump announced a 100% tariff increase, Asian pharmaceutical stocks may fall
6 m ago
Leading in competitiveness globally, China's biomanufacturing industry has reached a total scale of nearly one trillion yuan.
7 m ago
On September 25th local time, Eli Lilly and Company announced that the European Commission has approved its Alzheimer's disease treatment drug Kisunla (donanemab) for market. This drug is used to treat specific cases of early symptomatic Alzheimer's disease.
See all latestmore
logo
Contact US
qr
+852 - 60190728
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.